Activation of kappa-opioid receptors in the nucleus ambiguus does not affect cardiovascular function or outcome following acute hemorrhage in the rat.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Brain Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8394179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New and Experimental Therapeutic Roles for Naloxone and Related Opioid Antagonists

  2012cited by this paper
• Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism

  1992cited by this paper
• The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat.

  1991cited by this paper
• Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.

  1990cited by this paper
• Endogenous opiates: 1989.

  1990cited by this paper
• Use of naloxone in septic shock.

  1989cited by this paper
• Prospective, controlled, randomized trial of naloxone infusion in early hyperdynamic septic shock.

  1989cited by this paper
• Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.

  1989cited by this paper
• Evidence for a role of endorphins in the cardiovascular pathophysiology of primate shock.

  1988cited by this paper
• Influence of endogenous opiates and cardiac afferents on renal nerve activity during haemorrhage in conscious rabbits.

  1988cited by this paper
• Naloxone requires circulating catecholamines to attenuate the cardiovascular suppression of endotoxic shock.

  1988cited by this paper
• Naloxone potentiates epinephrine's pressor actions in endotoxemic rats.

  1988cited by this paper
• Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist.

  1987cited by this paper
• High‐dose naloxone: Pharmacokinetics in patients in septic shock

  1987cited by this paper
• Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.

  1987cited by this paper
• Central opioid mechanisms and cardiovascular control in hemorrhagic hypotension.

  1987cited by this paper
• Prolonged disruption of plasma beta-endorphin dynamics after trauma in the nonhuman primate.

  1987cited by this paper
• Endorphins in primate hemorrhagic shock: beneficial action of opiate antagonists.

  1986cited by this paper
• Opiate antagonist in traumatic shock.

  1986cited by this paper
• Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent.

  1985cited by this paper
• Endogenous opioid activity in clinical hemorrhagic shock.

  1985cited by this paper
• Naloxone in septic shock.

  1985cited by this paper
• Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.

  1985cited by this paper
• Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.

  1985cited by this paper
• Opioids and neuropeptides: mechanisms in circulatory shock.

  1985cited by this paper
• The cardiovascular actions of morphine and the endogenous opioid peptides.

  1985cited by this paper
• Naloxone versus placebo in treatment of septic shock.

  1985cited by this paper
• Endogenous opioid peptides: critical care implications.

  1984cited by this paper
• Beneficial effect of i.c.v. naloxone in anaphylactic shock is mediated through peripheral beta-adrenoceptive mechanisms.

  1984cited by this paper
• Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus.

  1984cited by this paper
• Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of rat

  1984cited by this paper
• Autonomic effects of central injections of D-Ala2-Met-enkephalinamide (DAME) in the conscious monkey.

  1984cited by this paper
• Endogenous opioids: Physiologic and pathophysiologic actions

  1984cited by this paper
• Alteration in opiate receptors binding after hemorrhagic shock.

  1984cited by this paper
• Evaluation of naloxone for therapy of Escherichia coli shock. Species differences.

  1984cited by this paper
• Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock.

  1984cited by this paper
• Cardiovascular effects of endogenous opiate systems.

  1983cited by this paper
• Naloxone in septic shock

  1983cited by this paper
• Influence of central nervous system on arterial pressure during endotoxin shock.

  1983cited by this paper
• Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.

  1983cited by this paper
• Dynorphins and Leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats.

  1983cited by this paper
• Hemodynamic changes following corticosteroid and naloxone infusion in dogs subjected to hypovolemic shock without resuscitation.

  1983cited by this paper
• Naloxone in reversal of hypotension in septic shock.

  1983cited by this paper
• Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei.

  1983cited by this paper
• Central autonomic effects of dermorphin in conscious rats.

  1983cited by this paper
• Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors

  1983cited by this paper
• Morphine exacerbates anaphylactic shock in mice by stimulating central opiate receptors.

  1983cited by this paper
• Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.

  1983cited by this paper
• Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shock.

  1983cited by this paper
• Evidence for an involvement of mu-, but not delta- or kappa-opiate receptors in sympathetically and parasympathetically mediated cardiovascular responses to opiates upon anterior hypothalamic injection.

  1982cited by this paper
• Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.

  1982cited by this paper
• An inhibitory role of beta-endorphin in central cardiovascular regulation.

  1982cited by this paper
• Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.

  1982cited by this paper
• Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist.

  1982cited by this paper
• Delta versus mu receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats.

  1982cited by this paper
• Involvement of both adrenergic and cholinergic receptors in the cardiovascular effects of naloxone during hemorrhagic hypotension in the conscious rabbit.

  1982cited by this paper
• Effect of naloxone on the cardiovascular and sympathetic response to hypovolemic hypotension in the rat.

  1981cited by this paper
• Pressor effect of naloxone in septic shock.

  1981cited by this paper
• The immunocytochemical localization of enkephalin in the central nervous system of the rat

  1981cited by this paper
• Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.

  1981cited by this paper
• Naloxone reversal of hypovolemic shock in dogs.

  1981cited by this paper
• Naloxone reverses the pathophysiology of shock through an antagonism of endorphin systems.

  1981cited by this paper
• The reversal of hemorrhagic hypotension by naloxone in conscious rabbits.

  1981cited by this paper
• Mechanism of naloxone therapy in the treatment of shock: a hypothesis.

  1981cited by this paper
• Multiple opiate receptors: emerging concepts.

  1981cited by this paper
• Ventriculocisternal administration of naloxone protects against severe hypotension during endotoxin shock.

  1980cited by this paper
• Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.

  1980cited by this paper
• Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock.

  1980cited by this paper
• Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock.

  1980cited by this paper
• Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists.

  1980cited by this paper
• Naloxone in irreversible shock.

  1980cited by this paper
• Enkephalin Effects on Blood Pressure, Heart Rate, and Baroreceptor Reflex

  1980cited by this paper
• Opiate antagonists: a role in the treatment of hypovolemic shock.

  1979cited by this paper
• Neurogenesis of respiratory rhythm in the mammal.

  1979cited by this paper
• Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock

  1978cited by this paper
• Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats.

  1978cited by this paper
• Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla.

  1977cited by this paper
• Central cardiovascular effects of morphinomimetic peptides in dogs.

  1977cited by this paper

• Cerebral mechanisms in cardiovascular control : Studies on haemorrhage and effects of sodium

  2007cites this paper
• STUDIES ON HAEMORRHAGE AND EFFECTS OF SODIUM

  2007cites this paper
• Endogenous opiates: 1993

  2003cites this paper
• U50,488H-induced pressor effect in the ovine foetus is mediated by sympathetic activation and vasopressin.

  1996cites this paper